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MEETING ABSTRACT Open Access
Robust neutralising activity and activation of
neutrophil cytotoxic responses mediated by
antibodies targeting the HTLV-1 envelope
glycoprotein
Chien-Wen Kuo, Lindsay Tulloch, David W Brighty*
From 15th International Conference on Human Retroviruses: HTLV and Related Viruses
Leuven and Gembloux, Belgium. 5-8 June 2011
Infection of human cells by Human T-cell leukaemia
virus (HTLV-1) is mediated by the viral envelope glyco-
proteins. The gp46 surface glycoprotein binds to a cell
surface receptors, including heparan sulphate proteogly-
cans, neuropilin-1, and Glut-1, allowing the transmem-
brane glycoprotein to initiate fusion of the viral and
cellular membranes. The envelope glycoproteins are
recognised by neutralising antibodies and cytotoxic T
lymphocytes following a protective immune response,
and therefore represent attractive components for an
HTLV-1 vaccine. Here we begin to explore the immu-
nological properties of recombinant SU as a potential
subunit vaccine candidate. We have used a soluble
recombinant gp46 fused to the Fc-region of human IgG
(sRgp46-Fc) as an immunogen to vaccinate mice and
generate monoclonal antibodies (mAbs) targeting SU.
The recombinant SU protein is highly immunogenic,
inducing high titre antibody responses to the immuno-
gen and facilitating selection of hybridomas that secrete
anti-SU mAbs. Many of these mAbs recognise envelope
expressed by HTLV-1 infected cells and these antibodies
strongly stimulate neutrophil-mediated cytotoxic
responses. Moreover, several of the mAbs directly and
robustly antagonise envelope-mediated fusion and neu-
tralize pseudovirus infectivity. While antibodies targeting
either the receptor-binding domain or C-terminal
domain of SU exhibit anti-viral activity, the most
potently neutralizing mAbs tend to recognise epitopes
that cluster in the N-terminal receptor-binding domain
of SU. Thus, our data demonstrate that recombinant
forms of SU possess immunological features that are of
direct utility to subunit vaccine design.
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